IE47642B1 - 4"-acylamino-4"-deoxy derivatives of oleandomycin,erythromycins a and b, and erythromycylamine - Google Patents

4"-acylamino-4"-deoxy derivatives of oleandomycin,erythromycins a and b, and erythromycylamine

Info

Publication number
IE47642B1
IE47642B1 IE5/79A IE579A IE47642B1 IE 47642 B1 IE47642 B1 IE 47642B1 IE 5/79 A IE5/79 A IE 5/79A IE 579 A IE579 A IE 579A IE 47642 B1 IE47642 B1 IE 47642B1
Authority
IE
Ireland
Prior art keywords
compound
formula
hydrogen
deoxy
methyl
Prior art date
Application number
IE5/79A
Other languages
English (en)
Other versions
IE790005L (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE790005L publication Critical patent/IE790005L/xx
Publication of IE47642B1 publication Critical patent/IE47642B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE5/79A 1978-01-03 1979-01-02 4"-acylamino-4"-deoxy derivatives of oleandomycin,erythromycins a and b, and erythromycylamine IE47642B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86672278A 1978-01-03 1978-01-03
US05/937,640 US4180654A (en) 1978-01-03 1978-08-29 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate

Publications (2)

Publication Number Publication Date
IE790005L IE790005L (en) 1979-07-03
IE47642B1 true IE47642B1 (en) 1984-05-16

Family

ID=27127966

Family Applications (1)

Application Number Title Priority Date Filing Date
IE5/79A IE47642B1 (en) 1978-01-03 1979-01-02 4"-acylamino-4"-deoxy derivatives of oleandomycin,erythromycins a and b, and erythromycylamine

Country Status (28)

Country Link
US (1) US4180654A (US08124317-20120228-C00026.png)
JP (1) JPS5495585A (US08124317-20120228-C00026.png)
AT (1) AT364457B (US08124317-20120228-C00026.png)
AU (1) AU506684B2 (US08124317-20120228-C00026.png)
CH (1) CH639972A5 (US08124317-20120228-C00026.png)
CS (1) CS204042B2 (US08124317-20120228-C00026.png)
DD (1) DD141026A5 (US08124317-20120228-C00026.png)
DE (2) DE2953969C2 (US08124317-20120228-C00026.png)
DK (1) DK147943C (US08124317-20120228-C00026.png)
ES (2) ES476544A1 (US08124317-20120228-C00026.png)
FI (1) FI68058C (US08124317-20120228-C00026.png)
FR (1) FR2413403A1 (US08124317-20120228-C00026.png)
GB (1) GB2013181B (US08124317-20120228-C00026.png)
GR (1) GR72779B (US08124317-20120228-C00026.png)
HU (1) HU180276B (US08124317-20120228-C00026.png)
IE (1) IE47642B1 (US08124317-20120228-C00026.png)
IL (1) IL56363A (US08124317-20120228-C00026.png)
IN (1) IN150395B (US08124317-20120228-C00026.png)
IT (1) IT1109925B (US08124317-20120228-C00026.png)
LU (1) LU80747A1 (US08124317-20120228-C00026.png)
NL (1) NL176461C (US08124317-20120228-C00026.png)
NO (2) NO146711C (US08124317-20120228-C00026.png)
NZ (1) NZ189274A (US08124317-20120228-C00026.png)
PH (4) PH14745A (US08124317-20120228-C00026.png)
PL (2) PL117603B1 (US08124317-20120228-C00026.png)
PT (1) PT69014A (US08124317-20120228-C00026.png)
SE (2) SE447118B (US08124317-20120228-C00026.png)
YU (2) YU312278A (US08124317-20120228-C00026.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6211669Y2 (US08124317-20120228-C00026.png) * 1980-10-06 1987-03-19
JPS5848285U (ja) * 1981-09-26 1983-04-01 コナミ工業株式会社 テ−ブル型テレビゲ−ム機
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
JPS62240086A (ja) * 1986-04-12 1987-10-20 株式会社 エ−ス電研 遊技機の前面構造
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
YU55690A (en) * 1990-03-21 1990-12-31 Pliva Pharm & Chem Works Process for preparing oleandomycin oxime
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
CA2525455A1 (en) * 2003-05-13 2004-11-25 Glaxo Group Limited Novel 14 and 15 membered-ring compounds
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884902A (en) * 1973-05-04 1975-05-20 Abbott Lab Sulfonyl derivatives of erythromycin
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
IE44509B1 (en) * 1976-03-03 1981-12-30 Pfizer Semi-synthetic oleandomycins
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin

Also Published As

Publication number Publication date
NO147716B (no) 1983-02-21
CH639972A5 (de) 1983-12-15
FR2413403B1 (US08124317-20120228-C00026.png) 1982-07-23
CS204042B2 (en) 1981-03-31
FI68058C (fi) 1985-07-10
HU180276B (en) 1983-02-28
NO146711C (no) 1982-11-24
ES476544A1 (es) 1979-12-01
NL176461C (nl) 1985-04-16
LU80747A1 (fr) 1979-09-07
US4180654A (en) 1979-12-25
JPS5495585A (en) 1979-07-28
FI790004A (fi) 1979-07-04
NO147716C (no) 1983-06-01
PT69014A (en) 1979-02-01
PL118573B1 (en) 1981-10-31
GB2013181B (en) 1982-06-03
SE448385B (sv) 1987-02-16
ATA2979A (de) 1981-03-15
PH15752A (en) 1983-03-18
DD141026A5 (de) 1980-04-09
DE2900118A1 (de) 1979-07-05
DK147943C (da) 1985-08-05
SE447118B (sv) 1986-10-27
DK147943B (da) 1985-01-14
YU213982A (en) 1983-02-28
JPS5734280B2 (US08124317-20120228-C00026.png) 1982-07-22
IL56363A0 (en) 1979-03-12
IN150395B (US08124317-20120228-C00026.png) 1982-09-25
AU4298578A (en) 1979-07-12
SE8304417L (sv) 1983-08-15
SE8304417D0 (sv) 1983-08-15
DE2900118C2 (US08124317-20120228-C00026.png) 1987-09-17
NO790006L (no) 1979-07-04
NO146711B (no) 1982-08-16
DE2953969C2 (US08124317-20120228-C00026.png) 1987-09-03
PH14745A (en) 1981-11-20
NZ189274A (en) 1982-03-23
AT364457B (de) 1981-10-27
PH15626A (en) 1983-03-11
IT7919013A0 (it) 1979-01-02
NO820613L (no) 1979-07-04
GB2013181A (en) 1979-08-08
PL212593A1 (pl) 1979-08-27
AU506684B2 (en) 1980-01-17
DK507778A (da) 1979-07-04
SE7900028L (sv) 1979-07-04
IL56363A (en) 1982-12-31
IT1109925B (it) 1985-12-23
NL7900006A (nl) 1979-07-05
YU312278A (en) 1983-01-21
FI68058B (fi) 1985-03-29
GR72779B (US08124317-20120228-C00026.png) 1983-12-05
PL117603B1 (en) 1981-08-31
FR2413403A1 (fr) 1979-07-27
PH15439A (en) 1983-01-18
IE790005L (en) 1979-07-03
ES482420A1 (es) 1980-09-01

Similar Documents

Publication Publication Date Title
CA2118488C (en) 5-o-desosaminylerythronolide a derivative
RU2141965C1 (ru) Производные эритромицина, способы их получения и фармацевтическая композиция на их основе
RU2114859C1 (ru) Производные эритромицина, фармацевтическая композиция, способ получения производных эритромицина
IE47642B1 (en) 4"-acylamino-4"-deoxy derivatives of oleandomycin,erythromycins a and b, and erythromycylamine
EP0087905B1 (en) 4"-epi erythromycin a and derivatives thereof as useful antibacterial agents
US4090017A (en) 4-Deoxy-4-substituted amino derivatives of oleandomycin
US4150220A (en) Semi-synthetic 4"-erythromycin A derivatives
US4085119A (en) 4-Substituted amino derivatives of oleandomycin
DE602004003054T2 (de) Neue 3-decladinosyl-9a-n-carbamoyl- und 9a-n-thiocarbamoylderivate von 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a
CA1126726A (en) 4"-deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
CA1126725A (en) 4"-deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4166901A (en) 4"-Deoxy-4"-arylglyoxamido- and aroylthioformamido derivatives of oleandomycin and its esters
SE445223B (sv) Sett att framstella 4"-amino-erytomylin-a-derivat
CA1151160A (en) Erythromycylamine 11,12-carbonate and derivatives thereof
US2966484A (en) Chemical compounds
CH661513A5 (de) 14-de-(hydroxymethyl)-mycaminosyltylonolid-verbindungen.
KR820001367B1 (ko) 올레안도마이신, 에리스로마이신 및 에리스로 마이신 카보네이트의 4"-데옥시-4"-아실아미도 유도체의 제조방법
Lalezari et al. Synthesis and antibacterial activity of 5-nitro-2-furfurylidene arylthioacethydrazides and 5-nitro-2-furfurylidene arylsulfonylacethydrazides
CN101326193B (zh) 红霉素化合物中3'-二甲基氨基的脱甲基化方法
FI68404B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4"deoxi-4"-aminoerytromycin-a-derivat
DK153761B (da) Analogifremgangsmaade til fremstilling af 4ae-deoxo-4ae-acylamidoderivater af erythromycylamin og erythromycyliminderivater til anvendelse som udgangsmateriale ved denne fremgangsmaade
KR19980080182A (ko) 에르트로마이신 부류로부터의 세코매크롤리드 및 그의 제조방법
DE1620736A1 (de) Verfahren zur Reduktion von Formylverbindungen
IE46662B1 (en) Erythromycin a intermediates

Legal Events

Date Code Title Description
MM4A Patent lapsed